Skip to main content
Signal8

Minerva Surgical, Inc. (UTRS)

Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring. Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices. The company was founded in 2008 and is headquartered in Santa Clara, California.

Sector: Medical - Devices

Industry: Medical - Devices

Minerva Surgical, Inc. logo

Minerva Surgical, Inc.

OTC:UTRSHealthcare
CLOSED
Mkt Cap-
EV-
Float961K
O/S8.88M
VOL260 sh
$ Vol$0
RVOL1.00×
Inst Own-
SI<0.1%
Net Cash/Sh-$3.69
EarningsNov 17 · Today
Dilution
Financials Summary
Revenue$50.29M
Net Income-$34.11M
Total Assets$68.9M
Free Cash Flow-$35.64M
Debt & Equity
Debt 70%
Equity 30%
Total Debt$39.69M
Total Equity$17.18M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:20Reverse split
    Oct 2, 202320 shares → 1
Balance Sheet Details
Assets$68.9M
Liabilities$51.72M
Accounts Receivable$7.24M
Accounts Payable$2.8M
Inventory$16.85M
PP&E (Net)$5.31M
Goodwill$0
Intangible Assets$26.78M
Income Statement
PeriodFY 2022FY 2021FY 2020FY 2019
CurrencyUSDUSDUSDUSD
Period Ending2022-12-312021-12-312020-12-312019-12-31
Revenue$50.29M$52.1M$37.77M$26.01M
YoY Growth-3.5%38.0%45.2%-
Cost of Revenue$23.05M$21.58M$18.65M$14.21M
Gross Profit$27.24M$30.52M$19.12M$11.8M
Gross Margin54.2%58.6%50.6%45.4%
Research and Development$5.44M$5.29M$3.32M$935K
Selling, General, and Administrative$52.7M$54.38M$31.19M$30.51M
Other$0$0$0$0
Total Operating Expenses$58.14M$59.67M$34.51M$31.44M
Operating Income (EBIT)-$30.9M-$29.14M-$15.39M-$19.64M
Operating Margin-61.4%-55.9%-40.7%-75.5%
Interest Expense$3.22M$11.73M$12.14M$17.58M
Interest Income$89K$10K$81K$135K
Other Income (Expense)-$3.2M$7.69M-$3M-$32.41M
Income Before Tax (EBT)-$34.1M-$21.45M-$18.39M-$52.05M
Income Tax Expense$11K$9K-$132K$0
Net Income-$34.11M-$21.46M-$18.26M-$52.05M
Net Income Margin-67.8%-41.2%-48.4%-200.1%
Supplementary Data
EPS-23.68-14.98-17.91-75.29
Diluted EPS-23.68-14.98-17.91-75.29
Weighted Average OS1.44M1.43M1.02M927,034
EBITDA-$20.07M$893K$821K-$32.79M
EBITDA Margin-39.9%1.7%2.2%-126.1%
Balance Sheet
PeriodFY 2022FY 2021FY 2020FY 2019
CurrencyUSDUSDUSDUSD
Period Ending2022-12-312021-12-312020-12-312019-12-31
Assets
Current Assets
Cash and Cash Equivalents$6.94M$40.61M$17.36M$27.09M
Short-Term Investments$0$0$0$0
Cash and Short-Term Investments$6.94M$40.61M$17.36M$27.09M
Accounts Receivable$7.24M$7.29M$8.38M$3.95M
Inventory$16.85M$15.68M$10.2M$4.74M
Other Current Assets$1.36M$7.43M$7.57M$7.37M
Total Current Assets$36.12M$75M$45.42M$43.81M
Long-Term Assets
Property, Plant & Equipment Net$5.31M$4.59M$2.88M$2.27M
Goodwill$0$0$0$0
Intangible Assets$26.78M$34.97M$43.14M$0
Long-Term Investments$265K$524K$604K$0
Deferred Tax Assets$0$0$0$0
Other Long-Term Assets$426K$524K$0$604K
Total Long-Term Assets$32.78M$40.09M$46.63M$2.87M
Other Assets$0$0$0$0
Total Assets$68.9M$115.09M$92.05M$46.68M
Liabilities
Current Liabilities
Accounts Payable$2.8M$3.63M$3.51M$4.19M
Short-Term Debt$1.89M$189K$1.67M$0
Current Income Tax Payable$271K$657K$754K$530K
Current Unearned Revenue$339K$206K$219K$51K
Other Current Liabilities$3.7M$8.61M$18.33M$2.66M
Total Current Liabilities$14.28M$22.81M$33.27M$15.22M
Long-Term Liabilities
Long-Term Debt$37.44M$39.09M$95.62M$75.89M
Long-Term Unearned Revenue$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0
Other Long-Term Liabilities$0$9.09M$184.97M$160.09M
Total Long-Term Liabilities$37.44M$48.37M$280.59M$235.99M
Other Liabilities$0$0$0$0
Total Liabilities$51.72M$70.99M$313.86M$251.21M
Stockholders' Equity
Preferred Stock$0$0$0$0
Common Stock$29K$28K$1K$1K
Retained Earnings-$283.67M-$249.56M-$228.09M-$209.83M
Comprehensive Income & Other$11K$11K$11K$11K
Other Stockholders' Equity$300.82M$293.63M$6.28M$5.3M
Total Equity$17.18M$44.1M-$221.81M-$204.52M
Minority Interest$0$0$0$0
Total Liabilities and Equity$68.9M$115.09M$92.05M$46.68M
Supplementary Data
Total Debt$39.69M$39.27M$97.29M$75.89M
Net Debt$32.75M-$1.33M$79.93M$48.81M
Cash Flow Statement
PeriodFY 2022FY 2021FY 2020FY 2019
CurrencyUSDUSDUSDUSD
Period Ending2022-12-312021-12-312020-12-312019-12-31
Operating Activities
Net Income-$34.11M-$21.46M-$18.26M-$52.05M
Depreciation & Amortization$10.81M$10.62M$7.08M$1.68M
Deferred Income Tax$0-$19.42M-$132K$14.95M
Stock-Based Compensation$6.98M$6.82M$858K$587K
Changes in Working Capital:
  Accounts Receivable$48K$1.09M-$4.43M-$332K
  Inventory-$4.13M-$9.07M$1.26M$835K
  Accounts Payable-$881K$3.3M-$687K-$2.98M
  Other Working Capital-$6.08M-$3.86M$990K$368K
Total Working Capital Change-$11.05M-$8.55M-$2.87M-$2.11M
Other Non-Cash Items-$8.19M$9.62M$1.08M$17.16M
Net Cash from Operating-$35.57M-$22.38M-$12.24M-$19.79M
Investing Activities
Capital Expenditures-$73K-$584K-$453K-$223K
Acquisitions$0$0-$15M$0
Purchases of Investments$0$0$0$0
Sales of Investments$0$0$0$0
Other Investing Activities$0-$25M$0$0
Net Cash from Investing-$73K-$25.58M-$15.45M-$223K
Financing Activities
Debt Repaid--$4.16M-$17.96M-$43.81M
Common Stock Issuance$36K$70.72M$118K$110K
Common Stock Repurchases$0$0$0$0
Dividends Paid$0$0$0$0
Other Financing Activities-$5M-$3.67M$0-$764K
Net Cash from Financing-$4.96M$71.21M$18.08M$43.16M
Forex Effect$0$0$0$0
Net Change in Cash-$40.6M$23.25M-$9.62M$23.14M
Supplementary Data
Operating Cash Flow-$35.57M-$22.38M-$12.24M-$19.79M
Capital Expenditure-$73K-$584K-$453K-$223K
Free Cash Flow-$35.64M-$22.96M-$12.69M-$20.02M
Cash at Beginning$48.41M$25.17M$34.78M$11.64M
Cash at End$7.81M$48.41M$25.17M$34.78M